BrightGene (博瑞生物医药) is a research-driven biopharmaceutical company that engages in the R&D and manufacturing of medicines. Its products include immuno-oncological therapeutic agents, antibody-drug conjugates for solid tumor, non-antibody dependent tumor-targeting conjugates for brain cancer and solid tumor brain-metastasis, etc.